Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Drug-controlled CAR T cells through the regulation of cell-cell interactions.

Nature chemical biology·2026
Same author

Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2.

Nature biomedical engineering·2025
Same author

Dissecting the role of CAR signaling architectures on T cell activation and persistence using pooled screens and single-cell sequencing.

Science advances·2025
Same author

The physiological landscape and specificity of antibody repertoires are consolidated by multiple immunizations.

eLife·2024
Same author

Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies.

Nature biomedical engineering·2024

相关实验视频

Updated: Jul 6, 2025

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.6K

通过合成进化和机器学习推进抗体工程.

Edward B Irvine1, Sai T Reddy1

  • 1Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.

Journal of immunology (Baltimore, Md. : 1950)
|January 2, 2024
PubMed
概括
此摘要是机器生成的。

抗体 (Abs) 是一种多功能疗法. 先进的工程和机器学习加速了用于药物开发和传染病治疗的合成抗体的设计.

科学领域:

  • 生物技术是生物技术.
  • 蛋白质工程是指蛋白质工程.

更多相关视频

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.8K
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

13.7K

相关实验视频

Last Updated: Jul 6, 2025

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.6K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.8K
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

13.7K
  • 免疫学 免疫学 免疫学

    • 背景情况:

    • 抗体 (Abs) 是关键的治疗分子,具有高的向结合亲和力和有利的生物物理性质.
    • 合成抗体的发现和工程已经被蛋白质显示和定向进化系统彻底改变.
    • 高通量查,深度测序和机器学习正在增强体外抗体优化.

    结论:

    • 通过综合实验和计算方法,合成抗体工程正在迅速发展.
    • 机器学习有望克服治疗挑战,特别是在传染病方面.
    • 未来的抗体设计可以由人工智能指导,以创建针对不断演变的病原体的强大的治疗方法.